T2 Biosystems DSO Ratio 2011-2026 | TTOO

Annual DSO Ratio T2 Biosystems

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
91.3	59.7	66.3	79.8	101	229	31.1	31.1	37	308	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
308	31.1	104

Quarterly DSO Ratio T2 Biosystems

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
75.8	67.8	66.4	-	75.9	62.1	76.5	-	53.3	54.7	59.9	-	50.4	54.6	59.9	-	44.9	67.1	94.6	65.4	74.9	74.7	91	89.6	61.5	25.2	20.7	25	58.6	66.3	35.7	35.4	28.1	29.9	30.4	33.7	33.4	38.6	70.1	154	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
154	20.7	58.5

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Castle Biosciences CSTL	50.2	$ 20.03	4.32 %	$ 581 M	USA
Fulgent Genetics FLGT	77.4	$ 16.41	2.88 %	$ 496 M	USA
Guardant Health GH	46.1	$ 114.97	17.09 %	$ 14.4 B	USA
ICON Public Limited Company ICLR	68.5	$ 115.09	1.36 %	$ 9.49 B	Irlanda
Interpace Biosciences IDXG	66.9	$ 1.8	-	$ 7.96 M	USA
Agilent Technologies A	63.8	$ 113.78	2.96 %	$ 34.6 B	USA
Illumina ILMN	61.3	$ 141.92	0.17 %	$ 22.6 B	USA
Co-Diagnostics CODX	94.7	$ 2.39	21.32 %	$ 3.18 M	USA
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
CareDx, Inc CDNA	51.5	$ 21.15	3.02 %	$ 1.13 B	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Lantheus Holdings LNTH	80.5	$ 96.09	3.44 %	$ 6.49 B	USA
Medpace Holdings MEDP	50.4	$ 421.87	0.47 %	$ 12.2 B	USA
Mettler-Toledo International MTD	66.4	$ 1 082.67	3.04 %	$ 22.3 B	Schweiz
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
National Research Corporation NRC	29.4	$ 19.26	2.72 %	$ 431 M	USA
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Natera NTRA	81.5	$ 204.92	4.53 %	$ 20.2 B	USA
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
Personalis PSNL	63.8	$ 7.95	12.93 %	$ 709 M	USA
Charles River Laboratories International CRL	65	$ 156.03	2.36 %	$ 7.73 B	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
NeoGenomics NEO	77.7	$ 8.9	6.08 %	$ 1.14 B	USA
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Myriad Genetics MYGN	52.3	$ 3.81	7.32 %	$ 353 M	USA
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
Thermo Fisher Scientific TMO	70	$ 451.79	0.89 %	$ 170 B	USA
Senseonics Holdings SENS	1.04	$ 5.71	3.07 %	$ 238 M	USA
Twist Bioscience Corporation TWST	44.5	$ 53.66	8.4 %	$ 3.21 B	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	27	-	-	$ 2.69 B	USA
Biomerica BMRA	57.7	$ 2.35	-1.26 %	$ 5.4 M	USA
Trinity Biotech plc TRIB	87.2	$ 0.6	6.95 %	$ 216 M	Irlanda
Laboratory Corporation of America Holdings LH	52.9	$ 257.42	1.47 %	$ 21.4 B	USA
Waters Corporation WAT	306	$ 341.32	2.42 %	$ 20.3 B	USA
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	66.6	$ 8.83	5.75 %	$ 1.92 B	USA
Quest Diagnostics Incorporated DGX	44.9	$ 193.75	1.92 %	$ 21.5 B	USA